SALE
市場調查報告書

幹細胞療法的全球市場 - 預測和機會:2025年

Global Stem Cell Therapy Market By Type, By Source of Stem Cells, By Application, By End Users, By Region, Forecast & Opportunities, 2025

出版商 TechSci Research 商品編碼 934819
出版日期 內容資訊 英文 118 Pages
商品交期: 請詢問到貨日
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

幹細胞療法的全球市場 - 預測和機會:2025年 Global Stem Cell Therapy Market By Type, By Source of Stem Cells, By Application, By End Users, By Region, Forecast & Opportunities, 2025
出版日期: 2020年05月01日內容資訊: 英文 118 Pages
簡介

本報告提供全球幹細胞療法市場相關調查分析,提供市場規模·佔有率·預測,各市場區隔分析,競爭分析,市場趨勢的變化,新興機會相關的系統性資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 摘要整理

第4章 客戶的迴響

第5章 全球幹細胞療法市場預測

  • 市場規模與預測
    • 各金額
  • 市場佔有率與預測
    • 各類型
    • 各幹細胞來源
    • 各用途
    • 各終端用戶
    • 各企業
    • 各地區
  • 產品市場地圖

第6章 亞太地區的幹細胞療法市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 亞太地區:各國分析

第7章 歐洲的幹細胞療法市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 歐洲:各國分析

第8章 北美的幹細胞療法市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 北美:各國分析

第9章 南美的幹細胞療法市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 南美:各國分析

第10章 中東·非洲的幹細胞療法市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 中東·非洲:各國分析

第11章 市場動態

  • 促進因素
  • 課題

第12章 市場趨勢與發展

第13章 競爭情形

第14章 策略性建議

第15章 出版社和免責聲明

目錄
Product Code: 4488

Global stem cell therapy market is expected to grow at a formidable rate of around 12% during the forecast period. The global stem cell therapy market is driven by the growing popularity and awareness pertaining to the use of stem cells for the prevention and cure of certain life threatening diseases. Additionally, increase in number of stem cell banks and growing investments by the government and private organizations for the development of stem cell preservation infrastructure is further propelling the market across the globe.

The global stem cell therapy market is segmented based on type, source of stem cells, application, end users, company and region. Based on type, the market can be categorized into allogeneic, autologous and syngeneic. The allogenic type segment is expected to register the highest growth during forecast period attributable to the rising commercialization of allogeneic stem cell therapy products, wider therapeutic applications of allogeneic stem cells, easy production scale-up process, growing number of clinical trials related to allogeneic stem cell therapies, among others. Based on end users, the market can be bifurcated into hospitals and clinics. The hospitals segment is expected to dominate the market during the forecast years. This can be accredited to the rising preference for stem cell therapies offered by hospitals proves beneficial for the business growth. Hospitals have affiliations with research laboratories and academic institutes that carry out research activities for developing stem cell therapies. On introduction and approval of any novel stem therapy, hospitals implement it immediately.

Regionally, the stem cell therapy market has been segmented into various regions namely Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these regions, North America is expected to dominate the overall stem cell therapy market during the next five years on account of the increasing number of clinical trials for stem cell-based products and increasing public-private funding & research grants.

Major players operating in the global stem cell therapy market include Osiris Therapeutics, Inc., MEDIPOST Co., Ltd., Anterogen Co., Ltd., Pharmicell Co., Ltd., Holostem Terapie Avanzate S.r.l., JCR Pharmaceuticals Co., Ltd., NuVasive, Inc., RTI Surgical, Inc., AlloSource, Thermo Fisher Scientific and others. The companies are developing advanced technologies and launching new services in order to stay competitive in the market.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and forecast the market size of global stem cell therapy market.
  • To classify and forecast global stem cell therapy market based on type, source of stem cells, application, end users, company and regional distribution.
  • To identify drivers and challenges for global stem cell therapy market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global stem cell therapy market.
  • To identify and analyze the profile of leading players operating in global stem cell therapy market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals/clinics across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals/clinics, end users, channels and presence of all major players across the globe.

TechSci Research calculated the market size of global stem cell therapy market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Stem Cell therapy hospitals, clinics and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to stem cell therapy
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals, clinics and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global stem cell therapy market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Type:

Allogeneic

Autologous

Syngeneic

  • Market, By Source of Stem Cells:

Adipose Tissue

Bone Marrow

Neural

Embryo/Cord Blood Derived

iPSCs

Others

  • Market, By Application:

Musculoskeletal

Wound & Injury

Cardiovascular Disease (CVD)

Surgery

Acute Graft-Versus-Host Disease

Drug Discovery & Development

Others

  • Market, By End Users:

Hospitals

Clinics

  • Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global stem cell therapy market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Stem Cell Therapy Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Allogeneic, Autologous, Syngeneic)
    • 5.2.2. By Source of Stem Cells (Adipose Tissue, Bone Marrow, Neural, Embryo/Cord Blood Derived, iPSCs, Others)
    • 5.2.3. By Application (Musculoskeletal, Wound & Injury, Cardiovascular Disease (CVD), Surgery, Acute Graft-Versus-Host Disease, Drug Discovery & Development, Others)
    • 5.2.4. By End Users (Hospitals v/s Clinics)
    • 5.2.5. By Company (2019)
    • 5.2.6. By Region
  • 5.3. Product Market Map

6. Asia-Pacific Stem Cell Therapy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Source of Stem Cells
    • 6.2.3. By Application
    • 6.2.4. By End Users
    • 6.2.5. By Country
  • 6.3. Asia-Pacific: Country Analysis
    • 6.3.1. China Stem Cell Therapy Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Source of Stem Cells
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End Users
    • 6.3.2. India Stem Cell Therapy Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Source of Stem Cells
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End Users
    • 6.3.3. Australia Stem Cell Therapy Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Source of Stem Cells
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End Users
    • 6.3.4. Japan Stem Cell Therapy Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Type
        • 6.3.4.2.2. By Source of Stem Cells
        • 6.3.4.2.3. By Application
        • 6.3.4.2.4. By End Users
    • 6.3.5. South Korea Stem Cell Therapy Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Type
        • 6.3.5.2.2. By Source of Stem Cells
        • 6.3.5.2.3. By Application
        • 6.3.5.2.4. By End Users

7. Europe Stem Cell Therapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Source of Stem Cells
    • 7.2.3. By Application
    • 7.2.4. By End Users
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Stem Cell Therapy Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Source of Stem Cells
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End Users
    • 7.3.2. Germany Stem Cell Therapy Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Source of Stem Cells
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End Users
    • 7.3.3. United Kingdom Stem Cell Therapy Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Source of Stem Cells
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End Users
    • 7.3.4. Italy Stem Cell Therapy Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Source of Stem Cells
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End Users
    • 7.3.5. Spain Stem Cell Therapy Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Source of Stem Cells
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End Users

8. North America Stem Cell Therapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Source of Stem Cells
    • 8.2.3. By Application
    • 8.2.4. By End Users
    • 8.2.5. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Stem Cell Therapy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Source of Stem Cells
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End Users
    • 8.3.2. Mexico Stem Cell Therapy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Source of Stem Cells
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End Users
    • 8.3.3. Canada Stem Cell Therapy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Source of Stem Cells
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End Users

9. South America Stem Cell Therapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Source of Stem Cells
    • 9.2.3. By Application
    • 9.2.4. By End Users
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Stem Cell Therapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Source of Stem Cells
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End Users
    • 9.3.2. Argentina Stem Cell Therapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Source of Stem Cells
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End Users
    • 9.3.3. Colombia Stem Cell Therapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Source of Stem Cells
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End Users

10. Middle East and Africa Stem Cell Therapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Source of Stem Cells
    • 10.2.3. By Application
    • 10.2.4. By End Users
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Stem Cell Therapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Source of Stem Cells
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End Users
    • 10.3.2. Saudi Arabia Stem Cell Therapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Source of Stem Cells
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End Users
    • 10.3.3. UAE Stem Cell Therapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Source of Stem Cells
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End Users

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

  • 13.1. Osiris Therapeutics, Inc.
  • 13.2. MEDIPOST Co., Ltd.
  • 13.3. Anterogen Co., Ltd.
  • 13.4. Pharmicell Co., Ltd.
  • 13.5. Holostem Terapie Avanzate S.r.l.
  • 13.6. JCR Pharmaceuticals Co., Ltd.
  • 13.7. NuVasive, Inc.
  • 13.8. RTI Surgical, Inc.
  • 13.9. AlloSource
  • 13.10. Thermo Fisher Scientific

14. Strategic Recommendations

15. About Us & Disclaimer